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Chloramphenicol succinate a competitive substrate and inhibitor of succinate
dehydrogenase: relation to its mechanisms of toxicity
Ambekar CS, Kumana CR, Liang R and Cheung BMY. Faculty of Medicine, The University of Hong Kong.
Objective/Method: Chloramphenicol succinate (CAPS) causes marrow depression and in some cases severe aplastic
anaemia. Molecular mechanism of this toxicity is still unknown. We studied Ex-vivo metabolism of this antibiotic
by human bone marrow to investigate how it is metabolized and which enzyme is involved. To study metabolism
marrow samples were incubated with CAPS. To investigate involvement of succinate dehydrogenase (SDH) in
CAPS metabolism, marrow samples and rat liver mitochondria were incubated with CAPS in the presence and
absence of a known SDH activators and inhibitors at 370C. Detection of metabolites was carried out by HPLC.
Results: In 72 marrow samples, CAPS was slowly metabolized to chloramphenicol (CAP). In 20 marrow samples,
flavin adenine dinucleotide (FAD) enhanced CAP formation but reduction of FAD to FADH2 was inhibited. While
in 3 samples it was metabolized to CAP, nitroso-CAP and another metabolite. Marrow incubated with FAD (control)
showed FADH2 peak. No CAP formation was observed when marrow and CAPS were incubated with malonate and
3-NPA. Mitochondria metabolized CAPS to CAP. FAD, succinate and malonate enhanced CAP formation but
reduction of FADH2 was inhibited. While, oxaloacetate, 3-NPA and nitroso-CAP inhibited CAPS metabolism to
CAP.
Conclusions: These studies demonstrate that CAPS is a competitive substrate for SDH. In marrow and mitochondria,
it is oxidized to CAP by SDH and nitro metabolites formed may be responsible for inhibition of SDH. In some
marrows presence of SDH isoenzyme may be responsible for both oxidation and nitroreduction of CAPS to CAP,
nitroso-CAP and possibly hydroxylamino-CAP. SDH may be a target for CAPS induced marrow toxicity.
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